THE HOME FOR BIOPHARMA LAUNCH LEADERS TO REVOLUTIONISE LAUNCH STRATEGY & MANAGEMENT FROM CLINICAL DEVELOPMENT INTO POST-LAUNCH COMMERCIAL SUCCESS

3 - 4 December 2024 | Hotel London Olympia, UK

DOWNLOAD THE EVENT GUIDE

BECOME A SPONSOR

BOOK ONLINE NOW

Lena Lymperopoulou

Senior Global Government Affairs and Access, ex Novartis and Founder of the WEF Strategic PPPs Initiative for Cardiovascular Health

With 25 years of distinguished career in global health policy, Lena has recently led strategic initiatives to elevate cardiovascular disease (CVD) on global platforms such as the World Economic Forum. Her leadership at Novartis has been instrumental in driving policy changes across diverse markets and in establishing the EFPIA CV Health Platform, enhancing industry collaboration. Her earlier career at GlaxoSmithKline and at Burson-Marsteller Consultancy in Brussels reflect her extensive experience in shaping the market for vaccines, diabetes and rare diseases to broaden access and accelerate uptake of innovation. Her Government Affairs tenure in Greece during the 2010 economic crisis gave her the opportunity to shape healthcare reforms for the industry under the Troika Memorandum of Understanding. She was also a pioneer in pandemic preparedness in 2007-2009 well before COVID. Lena has a passion for advancing public private partnerships through strategic leadership and advocacy to create value for health systems and patients. Lena holds a BA in Journalism with a Certification in Value Based Healthcare from HBS.

Pharma Launch Excellence Summit Main Conference Day 1: Tuesday 3rd December

11:30 AM Roundtable Discussion: Health System and Market Strengthening: Alignment, Partnering and Integration for Launch Readiness

Setting the scene: The Centrality of Partnerships for Launch readiness 5 min

Chair : Troels Sørensen - Global Head Clinical Practice, Boehringer Ingelheim

Talk 1 : Target Population Outputs (TPOs) – is the market leady for launch? 7 min

Troels Sørensen – Head of Global Clinical Practice, Boehringer Ingelheim

Talk 2 : Evidence is the product – is the product launch ready ? 7 min

Laura Wallace – Head of Global Integrated Evidence - Boehringer Ingelheim

Talk 3: Engagement and Strategic PPPs at government level: market shaping for launch and uptake of innovations 7 min

Lena Lymperopoulou - Global Policy Executive, ex Novartis / GSK. Founder of the World Economic Forum Strategic PPPs initiative

Talk 4: Partnerships at health body and regional level: Access and launch readiness 7 min

Danny Moore - Strategic Account Director – Novartis

Talk 5: Partnerships at departmental level: Transforming Field medical to impact accountable launch leaders 7 min

Helen Kane – Global Medical Affairs and Field Medical Affairs Executive - ex-Novarts/Roche/Celgene. Founder of One MSL.

Panel discussion and questions 20 min

· Focus on the capabilities required by each respective function

Check out the incredible speaker line-up to see who will be joining Lena.

Download The Latest Agenda

In Partnership With :

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk